Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 874 results for "mylan"

Strides Arcolab Ltd settles for $150 million from Mylan

Strides Arcolab Ltd has agreed to receive from Mylan Inc., USA an amount of USD 150 Million as the full and final settlement against the Contingent Holdback of upto USD 250 Million. In view of this development, the Company intends to invest USD 20 ... Equity Bulls, 3 days ago

227 images for mylan

BioSpace, 1 week ago
Sports Eagle, 1 week ago
Peterborough Examiner, 1 week ago
Drug Discovery and Development, 1 week ago
Business Standard, 6 days ago
Business Standard India, 1 week ago
NBC Washington DC, 1 week ago
ABC News 4 Charleston, 1 week ago
Sys-Con Media, 1 week ago
Bioresearch Online, 1 week ago

Trial court denies injunction to BMS against Mylan from blocking access to generic HIV drug in Venezuela

In a huge relief to scores of HIV patients across Venezuala, on 26th September a Trial Court in Hyderabad denied an interim injunction to Bristol-Myers Squibb (BMS). On denying injunction the judge has expressly ruled that BMS has not made out a ...
 PharmaBiz2 days ago
Business Standard

Strides fails to get $250 mn of $1.7-bn transaction with Mylan

ides Arcolab, the Bangalore-based publicly held pharmaceutical company, said that it will be getting only $150 million of the $250 million which was supposed to flow into the company as part of an transaction with US-based generics major Mylan. Strides ...
 Business Standard6 days ago Strides fails to get $250 million of $1.7-billion transaction with Mylan  FirstWord Pharma6 days ago Strides to acquire Shasun for $200 million  Bio Spectrum Asia7 hours ago

Strides Arcolab slumps after final settlement with Mylan

Strides Arcolab fell 5.41% to Rs 665.50 at 11:45 IST on BSE after the company said it agreed to receive $150 million as the full and final settlement from US-based Mylan Inc. The announcement was made during trading hours today, 25 September ...
 Capital Market1 week ago Jordan's GMS to invest $29 mn in Strides Arcolab's biotech arm Stelis  Business Standard India2 days ago Strides to invest USD 20 mn in Biotech bizz  MyIris6 days ago
[x]  

Lupin, Aurobindo and Mylan bags outstanding exports awards for 2013-14

Lupin, Aurobindo and Mylan, have bagged Pharmexcil's top export awards for their outstanding export performances in the bulk drugs and formulations category for the year 2013-14. Out of more than 150 applications in exports category, Mumbai based ...
 PharmaBiz1 week ago Pharmexcil announces outstanding exports awards  Bio Spectrum Asia6 days ago

Strides to receive USD 150 mn for final settlement from Mylan

Strides Arcolab today announced that the company has agreed to receive an amount of USD 150 million from Mylan, USA. The amount is for the full and final settlement against the Contingent Holdback of upto USD 250 million. Strides Arcolab is a ...
 MyIris1 week ago
Business Standard

What Makes Mylan Attractive

Summary Mylan is one of the seven companies that have been granted a license by Gilead to sell generic version of the blockbuster hepatitis C drug Sovaldi in 91 developing countries. Even by conservative estimates, Sovaldi generic sales will ...
 Seeking Alpha2 weeks ago Mylan initiates Phase III asthma and diabetes trials  Individual.com2 weeks ago Mylan to test generic version of Advair Diskus for asthma treatment  Orthopedics Today2 weeks ago Mylan Commences Clinical Trials for Generic Versions of Advair Diskus and Insulin Analog to Lantus  Big News Network2 weeks ago
[x]  
Business Standard

VENUS TIES UP WITH MYLAN

[September 19, 2014] (Indian Business Insight Via Acquire Media NewsEdge) Venus Remedies Ltd has entered into marketing tie up with Mylan, generic drug manufacturer, Pennsylvania, through its subsidiary in Germany, Venus Pharma ...
 TMC Net1 week ago Venus Remedies : TIES UP WITH MYLAN  4 Traders1 week ago Venus Remedies surges 18% in three days on marketing tie-up with Mylan  Business Standard3 weeks ago Venus Pharma inks pact with Mylan for marketing meropenem in 3 European countries  Business Standard3 weeks ago
[x]  
Business Standard

Natco Pharma gains 5%; hits 52-week high

company announced that its marketing partner in the USA, Mylan Inc has filed ANDA and has been accepted by USFDA SI Reporter | Mumbai September 1, 2014 Last Updated at 13:25 IST Natco Pharma has gained 5% to Rs 1267 also its 52-week high on the BSE after the ...
 Business Standard1 month ago Natco Pharma hits record high  Business Standard1 month ago Natco Pharma at record high; partner Mylan files ANDA  Money Control1 month ago Natco Pharma`s partner Mylan files ANDA for Copaxone  Myiris1 month ago
[x]  

Venus Remedies up on pact with Mylan

In terms of volume, 3.14 lakh shares of the company changed hands at the BSE, while over 11 lakh shares were traded at the NSE during the day. MUMBAI: Shares of Venus Remedies surged over 8 per cent as Venus Pharma GmbH, a subsidiary of the pharma major ...
 Economic Times3 weeks ago Venus Remedies shares up as unit enters into pact with Mylan  Business Standard3 weeks ago Venus Remedies surges as unit enters into pact with Mylan  Business Standard3 weeks ago Venus Remedies extends recent steep rally  Business Standard3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - mylan
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less